DC federal court declines restraining order sought by Apotex

The District of Columbia federal court has declined to issue a temporary restraining order and preliminary injunction sought by Apotex to stop the FDA from delaying approval of its generic form of AstraZeneca's Prilosec. Apotex had sought to defeat a pediatric exclusivity patent extension on Prilosec.
You must be a registered member of MMM to post a comment.
close

Next Article in Careers

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.

Email Newsletters